3 As more employers incorporate digital GLP-1 programs, expect to see insurers incentivize treat-to-target approaches
The pharmacies themselves are mainly regulated by state boards of pharmacy, not the FDA
In failing heart tissue, the uptake and metabolism of these substrates are compromised, reducing oxidative phosphorylation and energy production [54]
And so, unfortunately, sometimes doctors or providers aren't always comfortable bringing it up with their patients
Medicaid coverage varies by state: While all states cover at least one Type 2 diabetes-indicated GLP-1, coverage for obesity-indicated options is inconsistent
In a follow-up proof-of-concept study by Aviles-Olmos et al., the longevity of motor and non-motor effects were assessed up to 24 months after the trial